Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,311,233)	$ (1,561,133)
Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued as compensation	53,098	51,398
Common shares issued as compensation and for services	38,250	38,250
Amortization of loan origination fees	9,825	0
Warrants granted to Scientific Advisory Board	1,986	908
Depreciation	175,162	172,811
Amortization	2,067	2,068
Change in fair value of derivative liabilities	0	(421,527)
Changes in operating assets and liabilities:
Prepaid expenses	44,257	49,419
Other assets	3,910	3,910
Accounts payable	(122,560)	346,864
Accounts payable - related party	(123,762)	(109,366)
Accrued expenses	(6,945)	(7,612)
NET CASH USED IN OPERATING ACTIVITIES	(2,235,945)	(1,434,010)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(34,985)	(4,139)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock and warrants	10,442,216	0
Deferred financing costs	(41,024)	(242,105)
Payment of loan payable	(47,034)	0
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	10,354,158	(242,105)
NET CHANGE IN CASH AND CASH EQUIVALENTS	8,083,228	(1,680,254)
Cash and cash equivalents at beginning of period	13,708,594	2,555,207
Cash and cash equivalents at end of period	21,791,822	874,953
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid	589	0
Income tax paid	$ 0	$ 0